Simplex Trading’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20K | Sell |
7,400
-7,000
| -49% | -$13K | ﹤0.01% | 7109 |
|
|
2026
Q1 | $17.3K | Buy |
14,400
+10,500
| +269% | +$12.8K | ﹤0.01% | 6892 |
|
|
2025
Q4 | $3.83K | Sell |
3,900
-16,500
| -81% | -$19.8K | ﹤0.01% | 7562 |
|
|
2025
Q3 | $25K | Buy |
20,400
+16,100
| +374% | +$17.4K | ﹤0.01% | 7129 |
|
|
2025
Q2 | $4K | Sell |
4,300
-5,700
| -57% | -$6.63K | ﹤0.01% | 7830 |
|
|
2025
Q1 | $7K | Sell |
10,000
-3,000
| -23% | -$3.68K | ﹤0.01% | 7314 |
|
|
2024
Q4 | $21K | Buy |
13,000
+11,900
| +1,082% | +$30K | ﹤0.01% | 6640 |
|
|
2024
Q3 | $3K | Sell |
1,100
-500
| -31% | -$1.95K | ﹤0.01% | 7828 |
|
|
2024
Q2 | $5K | Sell |
1,600
-2,200
| -58% | -$9.63K | ﹤0.01% | 7857 |
|
|
2024
Q1 | $27K | Buy |
+3,800
| New | +$23.5K | ﹤0.01% | 6836 |
|
|
2023
Q4 | – | Sell |
-600
| Closed | -$1K | – | 9074 |
|
|
2023
Q3 | $1K | Buy |
600
+300
| +100% | +$994 | ﹤0.01% | 8294 |
|
|
2023
Q2 | $1K | Sell |
300
-1,000
| -77% | -$5.52K | ﹤0.01% | 8610 |
|
|
2023
Q1 | $7K | Sell |
1,300
-8,600
| -87% | -$51.9K | ﹤0.01% | 7812 |
|
|
2022
Q4 | $99K | Buy |
9,900
+3,500
| +55% | +$65.7K | ﹤0.01% | 5086 |
|
|
2022
Q3 | $143K | Buy |
6,400
+3,000
| +88% | +$86.7K | ﹤0.01% | 5034 |
|
|
2022
Q2 | $84K | Sell |
3,400
-3,600
| -51% | -$99.3K | ﹤0.01% | 5795 |
|
|
2022
Q1 | $271K | Buy |
7,000
+6,300
| +900% | +$244K | ﹤0.01% | 4694 |
|
|
2021
Q4 | $40K | Sell |
700
-3,600
| -84% | -$204K | ﹤0.01% | 7529 |
|
|
2021
Q3 | $405K | Sell |
4,300
-100
| -2% | -$7.84K | ﹤0.01% | 4423 |
|
|
2021
Q2 | $381K | Buy |
4,400
+4,362
| +11,479% | +$351K | ﹤0.01% | 4578 |
|
|
2021
Q1 | $313K | Buy |
38
+9
| +31% | +$862 | ﹤0.01% | 4094 |
|
|
2020
Q4 | $263K | Buy |
29
+21
| +263% | +$1.3K | ﹤0.01% | 4248 |
|
|
2020
Q3 | $31K | Sell |
8
-319
| -98% | -$11.1K | ﹤0.01% | 6040 |
|
|
2020
Q2 | $1.12M | Sell |
327
-258
| -44% | -$7.69K | ﹤0.01% | 2039 |
|
|
2020
Q1 | $1.3M | Sell |
585
-179
| -23% | -$4.53K | ﹤0.01% | 1648 |
|
|
2019
Q4 | $1.5M | Buy |
764
+233
| +44% | +$3.7K | ﹤0.01% | 1738 |
|
|
2019
Q3 | $824K | Buy |
531
+356
| +203% | +$6.82K | ﹤0.01% | 2128 |
|
|
2019
Q2 | $355K | Sell |
175
-15
| -8% | -$270 | ﹤0.01% | 2903 |
|
|
2019
Q1 | $333K | Sell |
190
-19
| -9% | -$300 | ﹤0.01% | 3083 |
|
|
2018
Q4 | $268K | Buy |
209
+54
| +35% | +$753 | ﹤0.01% | 2841 |
|
|
2018
Q3 | $252K | Sell |
155
-18
| -10% | -$213 | ﹤0.01% | 3381 |
|
|
2018
Q2 | $196K | Buy |
173
+7
| +4% | +$77 | ﹤0.01% | 3512 |
|
|
2018
Q1 | $62K | Buy |
+166
| New | +$1.59K | ﹤0.01% | 2215 |
|
Other funds holding FATE
RG
JJ
Simplex Trading's FATE Position: Q2 2026 in Review
Simplex Trading reduced its Fate Therapeutics (FATE) stake by 70% in Q2 2026, selling an estimated $21.4K and leaving 4,866 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7465.
Simplex Trading first reported a position in FATE in Q3 2017 and has held it in 28 quarters since. The position peaked at $770K in Q3 2020. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.
- Simplex Trading held 4,866 shares of Fate Therapeutics worth $13.1K as of Q2 2026.
- Simplex Trading sold 11,570 Fate Therapeutics shares in Q2 2026, an estimated $21.4K.
- Fate Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7465 holding.
- Simplex Trading first reported a position in Fate Therapeutics in Q3 2017 and has held it in 28 quarters since.
- Simplex Trading's Fate Therapeutics position peaked at $770K in Q3 2020.
- 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.